Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





MEDLAB Middle East and Arab Health 2022 Edition Return as Co-Located Events for Healthcare and Laboratory Industries

By LabMedica International staff writers
Posted on 24 Jan 2022

Technology took centre stage at the 2022 edition of Arab Health and MEDLAB Middle East, the largest healthcare and laboratory exhibitions in the MENA region, organized by Informa Markets (London, UK).

The co-located events took place at the Dubai World Trade Centre from January 24-27 under the show themes of ‘United by business, forging ahead’ and ‘Connect with innovation that’s changing the face of diagnostics’. Both shows saw participants from nearly 160 countries and more than 60,000 attendees across the four days, with almost 4,000 exhibitors from the healthcare and laboratory industries.

More than 60 countries were represented, with over 20 dedicated country pavilions, making Arab Health and MEDLAB Middle East a genuinely global healthcare showcase. They included the UAE, Israel, Lebanon, Turkey, and a host of European countries such as the UK, Switzerland, Germany, Italy, France, Spain, Portugal, Slovenia, Hungary, Czech Republic, Poland, and Belgium. Russia, China, Taiwan, Japan, Korea, India, the US and Canada also had several exhibitors showcasing the latest technology and innovation through a range of healthcare products. Each pavilion hosted between 16 and 33 healthcare-related companies. In addition, the European Innovation Council Pavilion hosted 20 selected companies from across the healthcare landscape.

Underscoring the focus on technology, Arab Health 2022 featured the new Healthcare Transformation Zone which explored the latest tech advancements from global innovators and disruptors. The popular start-up competition, Innov8 Talks returned and featured 24 companies showcasing unique and innovative solutions. Rounding out the Transformation Zone was the launch of the Product Showcase segment, where a range of companies showcased ground-breaking innovations shaping the future of the healthcare and laboratory industries.

In another first for both events was the launch of the Future Health Summit. The high-level event was attended by over 150 senior government healthcare officials, CEOs and visionaries, from across the globe. As part of the Arab Health Congress, more than 550 regional and international speakers and over 2,500 delegates participated in 12 Continuing Medical Education (CME). With a total of nine conferences, MEDLAB Middle East Congress remains one of the largest CME accredited multi-track medical laboratory congresses globally, featuring over 100 renowned laboratory champions from around the world. Eight conferences took place live, in-person, and online, the new bonus track, Future of Lab.

"Arab Health and Medlab Middle East will once again reiterate the importance of the healthcare and laboratory industries as we continue to address the challenges posed by COVID-19 and provide a platform for developing solutions to overcome the pandemic," said Solenne Singer, Group Director for Informa Markets. "We have witnessed a clear uptick in demand from both buyers and exhibitors eager to meet in-person, to see firsthand the latest technology and innovation on the market, while also hearing from industry professionals from around the world on the latest trends and insights. This year, both events will be integral to ongoing global recovery, and we look forward to welcoming the industry to Dubai."

Related Links:
Informa Markets 

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.